GGrantIndex
← Leaderboards

Rui Zhao

Brookhaven Science Assoc-Brookhaven Lab

$12,492,651
Attributed
$15,103,972
Total exposure
17
Grants
12
Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.

Funding over time

peak $1.7M · FY200725
$2M$1.5M$1M$500K$0
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25

Funding mix

By agency

NIH$15,103,972 · 17

By mechanism

R01$9,745,663 · 6
R35$3,436,394 · 1
R21$993,655 · 3
R41$692,595 · 2
R03$224,738 · 3
P41$10,927 · 2

Top collaborators

Most similar at Brookhaven Science Assoc-Brookhaven Lab

Same institution · by research overlap

Others in their field

Top investigators on “Proteins

Research focus

ProteinsMolecularComplexStructureRna SplicingMrna PrecursorGene ExpressionBiochemicalIntronsEukaryotaSpliceosomesHuman DiseaseReactionProtein ComplexEssential GenesCellsMediatingGenetic TranscriptionSmall Nuclear RibonucleoproteinsMouse ModelFutureGeneticCatalytic DomainPlay

Grant awards (47)

The molecular mechanism of pre-mRNA splicing$825,573
R35 · FY2025 · GM · contact PI
Deciphering the role of EYA3/PP2A in triple negative breast cancer metastasis$647,118
R01 · FY2025 · CA
Understanding small molecule modulation of splicing for Huntington's disease therapy$195,000
R21 · FY2025 · NS · contact PI
The molecular mechanism of pre-mRNA splicing$825,573
R35 · FY2024 · GM · contact PI
Preclinical Studies to Develop an Eya2 Tyr Phosphatase Inhibitor as a Novel Medulloblastoma Therapeutic$399,709
R41 · FY2024 · CA
Equip Supplement- Refeyn TwoMP Mass Photometer$248,085
R35 · FY2024 · GM · contact PI
The molecular mechanism of pre-mRNA splicing$825,573
R35 · FY2023 · GM · contact PI
The molecular mechanism of pre-mRNA splicing$711,590
R35 · FY2022 · GM · contact PI
Role of Eya3 in regulating the immune microenvironment to promote breast tumor progression$620,565
R01 · FY2021 · CA
Understanding the structure and function of U1 snRNP$451,670
R01 · FY2021 · GM · contact PI
Structure and function of spliceosome$429,654
R01 · FY2021 · GM · contact PI
Role of Eya3 in regulating the immune microenvironment to promote breast tumor progression$620,565
R01 · FY2020 · CA
Understanding the structure and function of U1 snRNP$451,670
R01 · FY2020 · GM · contact PI
Structure and function of spliceosome$429,654
R01 · FY2020 · GM · contact PI
Role of Eya3 in regulating the immune microenvironment to promote breast tumor progression$601,947
R01 · FY2019 · CA
Understanding the structure and function of U1 snRNP$451,670
R01 · FY2019 · GM · contact PI
Structure and function of spliceosome$429,654
R01 · FY2019 · GM · contact PI
Role of Eya3 in regulating the immune microenvironment to promote breast tumor progression$620,565
R01 · FY2018 · CA
Understanding the structure and function of U1 snRNP$465,545
R01 · FY2018 · GM · contact PI
Structure and function of U5 snRNP$305,461
R01 · FY2018 · GM · contact PI
Role of Eya3 in regulating the immune microenvironment to promote breast tumor progression$51,338
R01 · FY2018 · CA
Role of Eya3 in regulating the immune microenvironment to promote breast tumor progression$24,146
R01 · FY2018 · CA
Role of Eya3 in regulating the immune microenvironment to promote breast tumor progression$614,111
R01 · FY2017 · CA
Structure and function of U5 snRNP$343,449
R01 · FY2017 · GM · contact PI
Structure and function of U5 snRNP$18,993
R01 · FY2017 · GM · contact PI
Structure and function of U5 snRNP$311,860
R01 · FY2016 · GM · contact PI
Developing cancer therapies through targeting the Six1/Eya transcriptional complex$202,928
R21 · FY2016 · CA
AKTA Pure Chromatography System$50,000
R01 · FY2016 · GM · contact PI
Structure and function of U5 snRNP$331,720
R01 · FY2015 · GM · contact PI
Spinal muscular atrophy therapy using recombinant SMN proteins$233,188
R21 · FY2015 · NS · contact PI
Developing cancer therapies through targeting the Six1/Eya transcriptional complex$168,789
R21 · FY2015 · CA
Spinal muscular atrophy therapy using recombinant SMN proteins$193,750
R21 · FY2014 · NS · contact PI
The anti-tumorigenic and anti-metastatic potential of Eya phosphatase inhibitors$292,886
R41 · FY2013 · CA
Identify Inhibitors of the Transcriptional Co-Repressor CtBP Using HTS for Cancer$37,416
R03 · FY2013 · DA · contact PI
Understanding the structure and function of splicing factor Prp8$269,920
R01 · FY2012 · GM · contact PI
Identify Inhibitors of the Transcriptional Co-Repressor CtBP Using HTS for Cancer$38,375
R03 · FY2012 · DA · contact PI
Identify inhibitors of the Six1/Eya interaction using high throughput screening$37,840
R03 · FY2012 · DA · contact PI
Understanding the structure and function of splicing factor Prp8$269,920
R01 · FY2011 · GM · contact PI
Identify inhibitors of the Six1/Eya interaction using high throughput screening$37,190
R03 · FY2011 · DA · contact PI
Identify inhibitors of the Eya phosphatase activity using high throughput screeni$36,717
R03 · FY2011 · DA · contact PI
Understanding the structure and function of splicing factor Prp8$272,646
R01 · FY2010 · GM · contact PI
Identify inhibitors of the Eya phosphatase activity using high throughput screeni$37,200
R03 · FY2010 · DA · contact PI
Understanding the structure and function of splicing factor Prp8$276,150
R01 · FY2009 · GM · contact PI
Understanding the structure and function of splicing factor Prp8$108,622
R01 · FY2009 · GM · contact PI
Understanding the structure and function of splicing factor Prp8$277,050
R01 · FY2008 · GM · contact PI
PRP8, A CRITICAL PRE-MRNA SPLICING FACTOR$6,110
P41 · FY2008 · RR · contact PI
PRP8, A CRITICAL PRE-MRNA SPLICING FACTOR$4,817
P41 · FY2007 · RR · contact PI